Endocan levels in patients with hyperprolactinemia

Authors

Institutions

Publication Details

Journal
BMC Endocrine Disorders
Published
2025-11-06
DOI
https://doi.org/10.1186/s12902-025-02079-9
Primary Topic
Inflammation biomarkers and pathways
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Endocan levels in patients with hyperprolactinemia

Ercan Tekin, Aşkın Güngüneş, Aykut Hacıömeroğlu
BMC Endocrine Disorders
Inflammation biomarkers and pathways
article

Endocan levels in patients with hyperprolactinemia

Ercan Tekin, Aşkın Güngüneş, Aykut Hacıömeroğlu
article en

Abstract

No abstract available for this paper.
BMC Endocrine DisordersVol. 25(1)
University of Turku (FI), State Hospital (GB)
Openalex Percentile: Top 65%
Inflammation biomarkers and pathways
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Endocan levels in patients with hyperprolactinemia — Ercan Tekin, Aşkın Güngüneş, et al. · BMC Endocrine Disorders (2025) | TGRS Research Map | TGRS